Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Pendyala

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 17, 2001
Phase I/pharmacodynamic study of N-acetylcysteine/oltipraz in smokers: early termination due to excessive toxicityL Pendyala, G Schwartz, W Bolanowska-Higdon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Phase I and pharmacokinetic study of etoposide phosphate by protracted venous infusion in patients with advanced cancerN Soni, N J Meropol, L Pendyala, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Phase I clinical trial of 1-(2-[2-(4-pyridyl)-2-imidazoline-1-yl]-ethyl)-3-(4-carboxy-phenyl) urea (CGP 15720A)P J Creaven, S Madajewicz, L Pendyala, et al.
Investigational New Drugs|January 1, 1997
Unusual central nervous system toxicity in a phase I study of N1N11 diethylnorspermine in patients with advanced malignancyP J Creaven, R Perez, L Pendyala, et al.
Cancer Investigation|October 13, 1999
Actual 5-year survival of patients with stage IIIB breast carcinoma: phase II trial of methotrexate, vinblastine, adriamycin, cisplatin, and folinic acidS Madajewicz, D Matei, P Hentschel, et al.
Seminars in Oncology|December 1, 1996
Early phase studies with paclitaxel/low-dose carboplatin in patients with solid tumorsP J Creaven, D Raghavan, R P Perez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
Intravenous ifosfamide/mesna is associated with depletion of plasma thiols without depletion of leukocyte glutathioneL Pendyala, P J Creaven, G Schwartz, et al.
Minerva Cardioangiologica|April 25, 2008
Review of percutaneous therapy for bifurcation lesions in the era of drug-eluting stentsL Pendyala, R Jabara, D Hou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1997
Translational studies of glutathione in bladder cancer cell lines and human specimensL Pendyala, S Velagapudi, K Toth, et al.
Progress in Clinical and Biological Research|January 1, 1985
Pharmacology and clinical studies with RU 23908 (Anandron)J P Raynaud, M Moguilewsky, C Tournemine, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 17, 2001
Phase I/pharmacodynamic study of N-acetylcysteine/oltipraz in smokers: early termination due to excessive toxicityL Pendyala, G Schwartz, W Bolanowska-Higdon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Phase I and pharmacokinetic study of etoposide phosphate by protracted venous infusion in patients with advanced cancerN Soni, N J Meropol, L Pendyala, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Phase I clinical trial of 1-(2-[2-(4-pyridyl)-2-imidazoline-1-yl]-ethyl)-3-(4-carboxy-phenyl) urea (CGP 15720A)P J Creaven, S Madajewicz, L Pendyala, et al.
Investigational New Drugs|January 1, 1997
Unusual central nervous system toxicity in a phase I study of N1N11 diethylnorspermine in patients with advanced malignancyP J Creaven, R Perez, L Pendyala, et al.
Cancer Investigation|October 13, 1999
Actual 5-year survival of patients with stage IIIB breast carcinoma: phase II trial of methotrexate, vinblastine, adriamycin, cisplatin, and folinic acidS Madajewicz, D Matei, P Hentschel, et al.
Seminars in Oncology|December 1, 1996
Early phase studies with paclitaxel/low-dose carboplatin in patients with solid tumorsP J Creaven, D Raghavan, R P Perez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
Intravenous ifosfamide/mesna is associated with depletion of plasma thiols without depletion of leukocyte glutathioneL Pendyala, P J Creaven, G Schwartz, et al.
Minerva Cardioangiologica|April 25, 2008
Review of percutaneous therapy for bifurcation lesions in the era of drug-eluting stentsL Pendyala, R Jabara, D Hou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1997
Translational studies of glutathione in bladder cancer cell lines and human specimensL Pendyala, S Velagapudi, K Toth, et al.
Progress in Clinical and Biological Research|January 1, 1985
Pharmacology and clinical studies with RU 23908 (Anandron)J P Raynaud, M Moguilewsky, C Tournemine, et al.
Pageof 6